Hopital Prive Dijon Bourgogne
- Address
- 22 Avenue Francoise Giroud, 21000 Dijon, France
Cardiovascular Research
The department focuses on chronic limb threatening ischemia in patients undergoing distal revascularization, evaluating whether extended dual anti‑platelet therapy can improve amputation‑free survival and overall mortality.
- Duration of antiplatelet treatment after endovascular procedures
- Limb salvage and functional outcomes
- Integration of anticoagulant background therapy
- Patient safety and bleeding risk assessment
These investigations are conducted at Hopital Prive Dijon Bourgogne, contributing to advances in vascular surgery across Europe.
Respiratory Research
The site is studying influenza‑induced acute hypoxemic respiratory failure, comparing the impact of early corticosteroid therapy on mortality, ventilator dependence, and intensive‑care stay.
- Early intervention strategies for severe influenza
- Effect on ventilator‑free and ICU‑free days
- Safety profile of systemic steroids in viral pneumonia
- Outcome measures for critical respiratory illness
This work reinforces the hospital’s role in respiratory medicine research within the French healthcare network.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hopital Prive Dijon Bourgogne
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Effect of One-Year versus One-Month Dual Antiplatelet Therapy Comprising Aspirin and Clopidogrel on Outcomes in Patients with Chronic Limb-Threatening Ischemia After Revascularization | Fondation Hopital Saint Joseph | Phase III | Recruiting | Jun 2026 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cefazolin Sodium | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.